Tiffany Yating Hsu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rheumatic Diseases | 8 | 2023 | 590 | 1.020 |
Why?
|
Spliceosomes | 2 | 2021 | 110 | 0.700 |
Why?
|
Genes, myc | 2 | 2015 | 399 | 0.570 |
Why?
|
Rheumatology | 4 | 2022 | 576 | 0.540 |
Why?
|
Antirheumatic Agents | 3 | 2022 | 1335 | 0.300 |
Why?
|
Arthritis, Rheumatoid | 4 | 2022 | 3695 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2021 | 987 | 0.270 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2022 | 2099 | 0.180 |
Why?
|
Autoimmune Diseases | 2 | 2022 | 2130 | 0.170 |
Why?
|
Myositis | 1 | 2022 | 251 | 0.170 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 173 | 0.170 |
Why?
|
Lung Injury | 1 | 2022 | 436 | 0.150 |
Why?
|
Introns | 2 | 2021 | 991 | 0.150 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 21 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 2940 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.130 |
Why?
|
RNA Splicing | 2 | 2021 | 907 | 0.130 |
Why?
|
Respiration, Artificial | 3 | 2021 | 2566 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 1011 | 0.120 |
Why?
|
RNA Precursors | 1 | 2015 | 206 | 0.120 |
Why?
|
Psoriasis | 1 | 2021 | 898 | 0.110 |
Why?
|
Breast Neoplasms | 3 | 2015 | 20774 | 0.110 |
Why?
|
Ribonucleoproteins | 1 | 2015 | 381 | 0.110 |
Why?
|
Glutarates | 1 | 2013 | 236 | 0.100 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2011 | 83 | 0.100 |
Why?
|
Mice, Nude | 2 | 2015 | 3689 | 0.100 |
Why?
|
Premature Birth | 1 | 2023 | 1713 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2015 | 8425 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2011 | 135 | 0.090 |
Why?
|
Isoxazoles | 1 | 2011 | 216 | 0.090 |
Why?
|
HeLa Cells | 1 | 2015 | 3127 | 0.080 |
Why?
|
Hospitalization | 4 | 2021 | 10232 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 2978 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4839 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 16665 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2410 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2015 | 2440 | 0.070 |
Why?
|
Thiophenes | 1 | 2011 | 590 | 0.070 |
Why?
|
Registries | 4 | 2022 | 8077 | 0.070 |
Why?
|
Cell Survival | 1 | 2015 | 5872 | 0.060 |
Why?
|
Neurogenesis | 1 | 2011 | 829 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4554 | 0.060 |
Why?
|
Gene Amplification | 2 | 2021 | 1062 | 0.060 |
Why?
|
Astrocytes | 1 | 2011 | 1266 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2014 | 3020 | 0.060 |
Why?
|
Female | 15 | 2023 | 379592 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Prednisolone | 1 | 2022 | 333 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2014 | 7721 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5851 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 13029 | 0.050 |
Why?
|
Humans | 19 | 2023 | 742088 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 289 | 0.040 |
Why?
|
Middle Aged | 9 | 2022 | 213127 | 0.040 |
Why?
|
Male | 11 | 2022 | 349538 | 0.040 |
Why?
|
Mice | 5 | 2021 | 81045 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8662 | 0.040 |
Why?
|
Prednisone | 1 | 2022 | 1567 | 0.040 |
Why?
|
Cytoplasm | 1 | 2021 | 1539 | 0.030 |
Why?
|
Signal Transduction | 2 | 2021 | 23387 | 0.030 |
Why?
|
Antibody Formation | 1 | 2021 | 1402 | 0.030 |
Why?
|
Glioma | 1 | 2011 | 3388 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1849 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2021 | 712 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15530 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3504 | 0.030 |
Why?
|
Alcohol Oxidoreductases | 1 | 2013 | 170 | 0.030 |
Why?
|
Animals | 5 | 2021 | 168561 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3292 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9715 | 0.020 |
Why?
|
Sumoylation | 1 | 2011 | 83 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6483 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3256 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8328 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 574 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3164 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2723 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2011 | 520 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40450 | 0.020 |
Why?
|
Aged | 4 | 2021 | 162944 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9846 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2013 | 870 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2085 | 0.020 |
Why?
|
Adult | 4 | 2022 | 213712 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 995 | 0.020 |
Why?
|
Metabolome | 1 | 2013 | 881 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10372 | 0.020 |
Why?
|
Mitosis | 1 | 2011 | 1208 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2011 | 789 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 2186 | 0.020 |
Why?
|
United States | 2 | 2022 | 69693 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2382 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 77098 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2964 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3444 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 25575 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1376 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4553 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29087 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10248 | 0.010 |
Why?
|
Mitochondria | 1 | 2013 | 3520 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2842 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 24913 | 0.010 |
Why?
|
DNA Methylation | 1 | 2013 | 4282 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3639 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53187 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9410 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10472 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 19223 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56350 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72145 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29010 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 85649 | 0.010 |
Why?
|
Neurons | 1 | 2011 | 9325 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 62966 | 0.000 |
Why?
|